Julien DIMASTROMATTEO

En résumé

Entreprises

• INSERM - Doctorant

  PARIS 13 maintenant

• Experimental Nuclear Cadiology & Molecular Imaging Lab, University of Virginia Health System - Research Associate

  2010 - maintenant - Development and validation of probes in the detection of vulnerable plaque.
  
  - Evaluation of New Myocardial Perfusion Agents for SPECT or PET Imaging.
  
  - Evaluation of A2A Receptor Agonists as Pharmacological Stress Agents for Myocardial Perfusion Imaging.
  
  - Toxicology Studies of Adenosine Receptor Agonists.
  
  - Development and Validation of Probe for Assessment of Therapeutical Treatment in Osteonecrosis.
  
  

Formations

• INSERM U877 Radiopharmaceutiques Biocliniques - Université Grenoble (Grenoble)

  Grenoble 2005 - 2010 PhD - Physiology, Medical Imaging - Evaluation of vulnerable plaque or myocardial angiogenesis targeted probes (Collaboration with ERAS Labo - St Nazaire les Eymes 38)

• Université Grenoble 1 Joseph Fourier

  La Tronche 2004 - 2005 Master 2 - Approche Spatio Temporelle des Systèmes vivants

• Université Grenoble 1 Joseph Fourier

  St Martin D'Heres 2001 - 2004 Biologie Cellulaire et Integrative

• Université Grenoble 1 Joseph Fourier

  La Tronche 1999 - 2001

Réseau

• Benoit BUSSER

• Evguéni MIRIOUCHKINE

• Guillaume ALLIX

• Lucie SANCEY

• Monique KERROCH

• Nicolas PINSAULT

• Robert LAFAYE

• Romain CARRON

• Sandrine DUFORT

• Soline CHAMBERT